Substantial evidence demonstrates that patients with hypertension exhibit pronounced systemic inflammatory responses characterized by elevated levels of proinflammatory mediators, such as IL-6, TNF-α, and C-reactive protein (CRP), along with a marked imbalance in anti-inflammatory pathways and PRLMs [118]. This evidence concerns the gene CRP and Hypertension.